PWMS News Search Results


Back to
   Back to PeopleWithMS NewsWire 

March 2008 Off the Wire . . .



03-03-08 Merck Serono Launches New Formulation Of Interferon Beta-1a
03-04-08 Multiple Sclerosis: Prognosis Better Than Expected
03-05-08 New SSDI Guidebook Available To Individuals With Mutiple Sclerosis
03-06-08 Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss During Optic Neuritis In A Preclinical Model Of Multiple Sclerosis
03-06-08 Chickenpox Virus in CSF is associated with MS relapses
03-07-08 Another twist on stem cells
03-07-08 MS Society Criticises Producers Of The Bill Over Made-up Drug, UK
03-07-08 Pixantrone To Be Studied In Phase I/II Trial For Aggressive Multiple Sclerosis
03-07-08 Evidence that Copaxone is neuroprotective
03-11-08 Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles.
03-11-08 The CB2 cannabinoid receptor controls myeloid progenitor trafficking. Involvement in the pathogenesis of an animal model of multiple sclerosis.
03-11-08 The influence of positive experiences on depression and quality of life in persons with multiple sclerosis.
03-11-08 [Subcutaneous interferon-beta-1a in the treatment of multiple sclerosis.]
03-11-08 Take Action: Help Move Research Forward
03-11-08 MS Trial Alert - Large Study of Oral Laqunimod Seeking Participants
03-12-08 Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts The Greatest Patient Share Among First And Second Line Therapies For Multiple Sclerosis
03-12-08 Accelerated Cure Project 2007 Annual Report Available
03-13-08 Richard Cohen's latest book “Strong at the Broken Places,”
03-13-08 Endless Pools, Inc. And National Multiple Sclerosis Society Raise Awareness For Healthy Living
03-13-08 Eye drug looked at in MS
03-13-08 Petition: Prevent Discrimination Against Workers with Disabilities
03-13-08 What Will You Do? Join The Movement To End Multiple Sclerosis During MS Awareness Week March 10-17
03-13-08 Opexa Therapeutics Announces Completion Of Mid Study Descriptive Analysis On Phase IIb Trial Of Tovaxin(R) For Treatment Of Multiple Sclerosis
03-14-08 Mouse Nerve Cells Protected From Damage By New Drug
03-19-08 Peptimmune Completes Phase I Study With A Novel Peptide Copolymer For The Treatment Of Multiple Sclerosis
03-21-08 New Tool To Study The Link Between Body Temperature And Severity Of MS Symptoms
03-21-08 Endless Pools Inc & National Multiple Sclerosis Society Fight Back Against MS - Unique Swimming Pools Promote Rehabilitation Through Aquatic Therapy
03-24-08 Gene-Environment Interactions Study Looks For Links To Motor Neuron Disease
03-24-08 EMEA Concludes New Advice To Doctors And Patients For Tysabri (natalizumab) Needed, Europe
03-25-08 BTG Initiates Clinical Study of Novel Multiple Sclerosis Treatment
03-25-08 Fox’s Janice Dean Reveals MS Diagnosis
03-26-08 Article about PatientsLikeMe in NY Times
03-27-08 Pixantrone To Be Studied In Phase I/II Trial For Aggressive MS
03-27-08 Loss Of Mobility Found To Impact Quality Of Life And Emotional And Financial Health Of Most People Living With Multiple Sclerosis
03-28-08 MS in focus
03-28-08 Various Forms Of Hope Among Patients With Amyotrophic Lateral Sclerosis
03-28-08 Some With MS Put Their Hopes in a Diet
03-31-08 Multiple Sclerosis Therapy Has Potential New Target
03-31-08 Descriptive Analysis on Phase IIb Trial of Tovaxin for Treatment of MS

E-Mail the NewsWire
 with any news items you discover 



©copyright 2003